144
Views
0
CrossRef citations to date
0
Altmetric
Meta Analysis

Serum Prealbumin As A Predictor of Adverse Outcomes in Patients with Heart Failure: A Systematic Review and Meta-Analysis

ORCID Icon, ORCID Icon & ORCID Icon
Pages 569-575 | Received 05 Dec 2021, Accepted 24 Feb 2022, Published online: 29 Mar 2022

References

  • Roger VL , WestonSA, RedfieldMMet al. Trends in heart failure incidence and survival in a community-based population. JAMA292(3), 344–350 (2004).
  • Kinugawa S , FukushimaA. Malnutrition in heart failure: important but undervalued issue. JACC. Heart failure6(6), 487–488 (2018).
  • Peng W , ZhangC, WangZ, YangW. Prediction of all-cause mortality with hypoalbuminemia in patients with heart failure: a meta-analysis. Biomarkers: biochemical indicators of exposure, response, and susceptibility to chemicals24(7), 631–637 (2019).
  • Ingenbleek Y , YoungV. Transthyretin (prealbumin) in health and disease: nutritional implications. Annu. Rev. Nutr.14, 495–533 (1994).
  • Marcason W . Should albumin and prealbumin be used as indicators for malnutrition?J. Acad. Nutr. Diet117(7), 1144 (2017).
  • Beck FK , RosenthalTC. Prealbumin: a marker for nutritional evaluation. Am. Fam. Physician65(8), 1575–1578 (2002).
  • Lourenco P , SilvaS, FrioesFet al. Low prealbumin is strongly associated with adverse outcome in heart failure. Heart100(22), 1780–1785 (2014).
  • Lu M , SuL, QinXL. Influence of pre-albumin and N-terminal pro-brain natriuretic peptide on the prognosis of elderly patients with chronic heart failure. J. Chin. Pract. Diagn. Ther.29(9), 848–851 (2015).
  • Yang H . Correlation analysis on prealbumin and the progosis of elderly patients with chronic heart failure. Thesis (MD). China Medical University (2016).
  • Franco J , FormigaF, TrullasJCet al. Impact of prealbumin on mortality and hospital readmission in patients with acute heart failure. Eur. J. Intern. Med.43, 36–41 (2017).
  • Critsinelis AC , KuriharaC, KawaboriM, SugiuraT, CivitelloAB, MorganJA. Preoperative prealbumin level as a predictor of outcomes in patients who underwent left ventricular assist device implantation. Am. J. Cardiol.120(11), 1998–2002 (2017).
  • Akashi M , MinamiY, HarukiS, JujoK, HagiwaraN. Prognostic implications of prealbumin level on admission in patients with acute heart failure referred to a cardiac intensive care unit. J. Cardiol.73(2), 114–119 (2019).
  • Shi L , ZhangY, ZhangJet al. Application of blood pre-albumin and NT-pro BNP levels in evaluating prognosis of elderly chronic heart failure patients. Exp. Ther. Med.20(2), 1337–1342 (2020).
  • Wells G , SheaB, O'connellDet al. The Newcastle–Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses (2022). http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
  • Han KY , ZhengY, ZhuCZ, ZhouXL, LinRZ, XiePD. Association of serum prealbumin level and long-term prognosis in patients with acute heart failure in the cardiac intensive care unit. Chinese Gen. Pract.23(18), 2266–2269 (2020).
  • Lau J , IoannidisJP, TerrinN, SchmidCH, OlkinI. The case of the misleading funnel plot. BMJ333(7568), 597–600 (2006).
  • Lourenco P , SilvaS, FrioesFet al. Does pre-albumin predict in-hospital mortality in heart failure? Int. J. Cardiol. 166(3), 758–760 (2013).
  • Collins N . The difference between albumin and prealbumin. Adv. Skin Wound Care14(5), 235–236 (2001).
  • El Iskandarani M , ElKurdi B, MurtazaG, PaulTK, RefaatMM. Prognostic role of albumin level in heart failure: a systematic review and meta-analysis. Medicine (Baltimore)100(10), e24785 (2021).
  • Mears E . Outcomes of continuous process improvement of a nutritional care program incorporating serum prealbumin measurements. Nutrition12(7–8), 479–484 (1996).
  • Devoto G , GalloF, MarchelloCet al. Prealbumin serum concentrations as a useful tool in the assessment of malnutrition in hospitalized patients. Clin. Chem.52(12), 2281–2285 (2006).
  • Michels Da Silva D , LangerH, GrafT. Inflammatory and molecular pathways in heart failure-ischemia, HFpEF and transthyretin cardiac amyloidosis. Int. J. Mol. Sci.20(9), 2322 (2019).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.